Organon (OGN) Change in Accured Expenses (2020 - 2026)

Organon has reported Change in Accured Expenses for 7 years, with the latest figure at -$20.0 million in Q2 2026.

• Change in Accured Expenses for Q2 2026 came in at -$20.0 million, up 79.59% year-over-year; the trailing twelve-month figure through Jun 2026 was -$8.0 million (up 88.24% YoY), and the FY2025 annual result was -$142.0 million, down 40.59% from the prior year.
• Change in Accured Expenses slipped to -$20.0 million in Q2 2026, from $95.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $165.0 million in Q3 2023 and troughed at -$156.0 million in Q4 2025.
• A 5-year average of $5.9 million and a median of -$11.5 million in 2022 frame the typical range for Change in Accured Expenses.
• The widest annual swing landed in 2023, when Change in Accured Expenses tumbled 950.0%; it then surged 360.0% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at $64.0 million in 2022, then advanced by 6.25% to $68.0 million in 2023, then slumped by 207.35% to -$73.0 million in 2024, then plunged by 113.7% to -$156.0 million in 2025, then surged by 87.18% to -$20.0 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were -$20.0 million in Q2 2026, $95.0 million in Q1 2026, and -$156.0 million in Q4 2025.